In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...
For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
Veracyte, Inc. , a leading genomic diagnostics company, today announced the publication of two studies demonstrating the Afirma GRID (Genomic Resource for Intelligent Discovery) research tool's ...
In “A House of Dynamite”, director Kathryn Bigelow uses multi-perspective storytelling to remind a new generation of the ...
Netsmart and McBee will reveal the latest innovations of the CareFabric® platform at the National Alliance for Care at Home Annual Meeting & Exposition, taking place from November 2-4 in New Orleans, ...
Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...
Uluu, an Australian company that has developed a biodegradable seaweed-based alternative to plastic, has raised AU$16 million ...
The Indian Institute of Technology-Madras announced a breakthrough artificial intelligence framework that can rapidly generate drug-like molecules that are easier to synthesise in real-world ...
The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...
According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...
Despite being plagued by a rash of disasters and safety concerns over the past several years, Boeing was awarded the F-47 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback